MindMed to Participate in March Investor Conferences
February 28 2023 - 07:30AM
Business Wire
Mind Medicine (MindMed) Inc. (NASDAQ: MNMD), (NEO: MMED), (the
"Company" or "MindMed"), a clinical stage biopharmaceutical company
developing novel product candidates to treat brain health
disorders, today announced that members of the Company's management
team will participate in the following investor conferences:
- Cowen 43rd Annual Healthcare Conference
- Format: Investor Presentation
- Date and Time: Wednesday, March 8, 2023 at 1:30 pm EST
- Webcast Link: Cowen Healthcare Conference
- Oppenheimer 33rd Annual Healthcare Conference
- Format: Investor Presentation
- Date and Time: Monday, March 13, 2023 at 2:00 pm EST
- Webcast Link: Oppenheimer 33rd Annual Healthcare
Conference
- 35th Annual Roth Conference
- Format: Fireside Chat
- Date and Time: Monday, March 13, 2023 at 2:30 pm PST/5:30 pm
EST
- Webcast Link: 35th Annual Roth Conference
Audio webcasts and replays of these presentations will be
available on MindMed’s Investor Resources website for up to 90 days
following each event.
About MindMed
MindMed is a clinical stage biopharmaceutical company developing
novel product candidates to treat brain health disorders. Our
mission is to be the global leader in the development and delivery
of treatments that unlock new opportunities to improve patient
outcomes. We are developing a pipeline of innovative product
candidates, with and without acute perceptual effects, targeting
neurotransmitter pathways that play key roles in brain health
disorders.
MindMed trades on NASDAQ under the symbol MNMD and on the
Canadian NEO Exchange under the symbol MMED.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20230228005602/en/
For Media & Investor Inquiries, please contact:
Maxim Jacobs, CFA Vice President, Investor Relations and
Corporate Communications Mind Medicine (MindMed) Inc. ir@mindmed.co media@mindmed.co
Mind Medicine MindMed (NASDAQ:MNMD)
Historical Stock Chart
From May 2023 to Jun 2023
Mind Medicine MindMed (NASDAQ:MNMD)
Historical Stock Chart
From Jun 2022 to Jun 2023